KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

NCT04165798 · clinicaltrials.gov ↗

RECRUITING

Status

1065

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DIAGNOSTIC_TEST: Tumor Imaging
PROCEDURE: Tumor Tissue Collection
PROCEDURE: Blood Sample Collection

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]